Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solifenacin Extension in Pediatric OAB
NCT01655069Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Oct 2012
- Primary completion
- Oct 2014
- Modality
- Orthosteric Ligands
- Countries
- 16
01
Overview
A Phase 3 trial of solifenacin in overactive bladder (OAB), sponsored by Astellas Pharma. Started Oct 2012; status: completed.
02
Drugs
solifenacin
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT01655069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01655069.